EU Mounts Pressure on AstraZeneca Over Reduction in COVID-19 Vaccine Supply

EU Mounts Pressure on AstraZeneca Over Reduction in COVID-19 Vaccine Supply

European Union wants AstraZeneca to honor the agreed-upon delivery schedule after recent news that the company wasn’t in a position to close that deal. Officials aren’t happy that the company is still delaying vaccine shipments when their countries are still recording mass deaths and skyrocketing coronavirus cases.

For instance, from the more than 100 million cases and 2.1 million deaths globally, the UK itself has recorded nearly 3.7 million cases with a death toll of more than 100,000. The other countries with huge numbers of death are the USA (+435K), Brazil (+218K), India (+153K), and Mexico (+152K).

If we were to check only cases in Europe, there are over 29.4 million confirmed coronavirus cases with more than 677K deaths. And that’s why the vaccine manufacturing companies need to act quickly enough to meet COVID-19 vaccine shipments.

On Tuesday, European Commission President Ursula von der Leyen released a video statement that clearly showed his disappointment after AstraZeneca failed to send the first coronavirus vaccine shipment. He stated that Europe had invested billions towards developing the world’s first COVID-19 vaccine, and therefore the relevant companies must deliver to honor their obligations.

This altercation came about after AstraZeneca announced on Friday that they were going to ship fewer doses of the vaccine than the amount that was initially agreed upon. The information was sent to the European Commission, which acts as the European Union’s executive arm.

Since then, the European Union is feeling let down by a company that they have invested a lot of money to create a vaccine that will reduce the number of new cases and deaths every day.

European Union commissioner Stella Kyriakides, who works under the health and food safety department, called AstraZeneca’s news as not acceptable at all. She explained there was a lack of clarity and insufficient explanations as to why the company was willing to reduce COVID-19 vaccines, which goes against the original agreement.

On Tuesday, AstraZeneca tried to convince the European Union why they had reduced COVID-19 vaccine shipments. The considerably fewer doses weren’t going to be welcomed by the European Union, and AstraZeneca must honor the agreed vaccine shipments quantity.

AstraZeneca spokesperson released a statement that read as follows:

“While there is no scheduled delay to the start of shipments of our vaccine should we receive approval in Europe, initial volumes will be lower than originally anticipated due to reduced yields at a manufacturing site within our European supply chain.” 

There was still no clear indication of what reduction meant and the number of doses the European Union wasn’t going to receive. The only thing the company said was that it would start rolling out COVID-19 vaccine doses in February and March. 

European Union is facing a devastating start to their immunization campaign for COVID-19 after the other vaccine manufacturing company – Pfizer, also talked of delaying their Europe’s shipment. 

Such delayed COVID-19 vaccine is not going on well with the European Union since they have spent 2.7 billion euros (around $3.2 billion) in vaccines’ production. 

Nelson Richards is a Seasoned Journalist with nearly 6 years of experience. While studying at Case Western Reserve University, Located at Cleveland. Nelson found a passion for finding and writing articles which are published in Well known Media Publications such as Tnt Publications and Ohio News Network. As a contributor to Chroniclex Nelson Covers National Topics.

Share this post